Repadevak 0.5mg Tablet
Marketer
Devak Formulations
Salt Composition
Repaglinide (0.5mg)
Overview Repadevak 0.5mg Tablet
Glycemia-reducing tablets of Repadevak (0.5mg) are indicated for adult patients with type 2 diabetes to manage elevated blood glucose. This medication is typically part of a broader treatment plan, often combined with other antidiabetic agents, to optimize glycemic control and mitigate serious diabetic complications such as nephropathy and retinopathy. Repadevak 0.5mg is usually initiated when dietary and exercise modifications, or other medications, prove insufficient to regulate blood sugar. Optimal efficacy is observed with pre-meal administration. Dosage is individualized based on patient condition and glucose readings, always following physician instructions. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Maintaining controlled blood glucose levels helps prevent future complications. Adherence to the prescribed diet and exercise regimen is crucial for overall diabetes management; lifestyle factors significantly influence disease control. Hypoglycemia (low blood sugar) is a prevalent adverse effect; carrying glucose tablets is recommended for rapid management. Additional reported side effects include abdominal discomfort, sinusitis, arthralgia, back pain, nausea, and diarrhea. Consult your physician if side effects are troublesome or persistent. Prior to commencing treatment, disclose any history of renal, cardiac, or pancreatic disease, or significant alcohol consumption. Pregnant or lactating individuals must seek medical counsel before initiating Repadevak. Potential drug interactions exist; inform your doctor of all concurrent medications. Alcohol consumption should be moderated due to the increased risk of hypoglycemia. Regular monitoring, including renal function tests and blood glucose measurements, ensures treatment effectiveness.
Primary Ingredients of Repadevak 0.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Repadevak 0.5mg Tablet
Managing type 2 diabetes
Major Benefits of Repadevak 0.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Repadevak 0.5mg Tablet on an empty stomach.
Common Side effects of Repadevak 0.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Nausea
- Diarrhea
- Back pain
- Joint pain
- Upper respiratory tract infection
- Headache
- Sinus inflammation
How to use Repadevak 0.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Repadevak 0.5mg Tablet on an empty stomach.
How Repadevak 0.5mg Tablet works:
Repadevak 0.5mg tablets function as an anti-diabetic agent by stimulating pancreatic insulin secretion, thereby moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Repadevak 0.5mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Repadevak 0.5mg Tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administering Repadevak 0.5mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Caution is advised when administering Repadevak 0.5mg tablets to individuals with advanced renal impairment. Dosage modification of Repadevak 0.5mg tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Repadevak 0.5mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Repadevak 0.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Repadevak 0.5mg Tablet :
Omit any missed Repadevak 0.5mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Repadevak 0.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Meglitinides |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action class | Meglitinides: Insulin Stimulators |
3,018 People bought this recently